<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) accounts for 1-2% of <z:hpo ids='HP_0000001'>all</z:hpo> cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) in the general population and for 35-40% in the setting of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The authors report a 9-year single-institution experience with 75 adult <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients (46 with and 29 without <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e>) and compare the clinical and pathologic features of the disease in the two groups of patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Between May 1987 and June 1995, 131 patients with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> and systemic NHL were diagnosed and treated at the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute in Aviano, Italy </plain></SENT>
<SENT sid="3" pm="."><plain>In 46 cases (35%), the diagnosis was <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>During the same period, 29 of 1004 HIV negative NHL patients (2.8%) were diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and treated at the same institution </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: No statistical differences were found in the general characteristics of the two groups at the time that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> was diagnosed </plain></SENT>
<SENT sid="6" pm="."><plain>Complete response rate was significantly lower for patients with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> than for those without <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> (40% vs. 65%, P = 0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>The median overall survival was significantly shorter for patients with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> (7 months vs. not yet reached, P = 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>However, the disease free survival (DFS) at 4 years was identical for the two groups of patients (74% for HIV positive patients vs. 73% for HIV negative patients, P = 0.70) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The data from this study show that patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> with and without <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> share similar clinicopathologic characteristics at presentation </plain></SENT>
<SENT sid="10" pm="."><plain>Although the median overall survival is significantly shorter for patients with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e>, the DFS is identical for both groups </plain></SENT>
</text></document>